Abstract

BackgroundLymphovascular invasion (VI) is an established prognostic marker for many cancers including bladder cancer. There is a paucity of data regarding whether the prognostic significance of lymphatic invasion (LVI) differs from blood vessel invasion (BVI). The aim was to examine LVI and BVI separately using immunohistochemistry (IHC), and investigate their associations with clinicopathological characteristics and prognosis. A secondary aim was to compare the use of IHC with assessing VI on standard HAS (hematoxylin-azophloxine-saffron) sections without IHC.MethodsA retrospective, population –based series of 292 invasive bladder cancers treated with radical cystectomy (RC) with curative intent at Vestfold Hospital Trust, Norway were reviewed. Traditional histopathological markers and VI based on HAS sections were recorded. Dual staining using D2–40/CD31 antibodies was performed on one selected tumor block for each case.ResultsThe frequency of LVI and BVI was 32 and 28%, respectively. BVI was associated with features such as higher pathological stages, positive regional lymph nodes, bladder neck involvement and metastatic disease whereas LVI showed weaker or no associations. Both BVI and LVI independently predicted regional lymph node metastases, LVI being the slightly stronger factor. BVI, not LVI predicted higher pathological stages. BVI showed reduced recurrence free (RFS) and disease specific (DSS) survival in uni-and multivariable analyses, whereas LVI did not. On HAS sections, VI was found in 31% of the cases. By IHC, 51% were positive, corresponding to a 64% increased sensitivity in detecting VI. VI assessed without IHC was significantly associated with RFS and DSS in univariable but not multivariable analysis.ConclusionsOur findings indicate that BVI is strongly associated with more aggressive tumor features. BVI was an independent prognostic factor in contrast to LVI. Furthermore, IHC increases VI sensitivity compared to HAS.

Highlights

  • Lymphovascular invasion (VI) is an established prognostic marker for many cancers including bladder cancer

  • Our findings indicate that blood vessel invasion (BVI) is strongly associated with more aggressive tumor features

  • IHC increases VI sensitivity compared to HAS

Read more

Summary

Introduction

Lymphovascular invasion (VI) is an established prognostic marker for many cancers including bladder cancer. Since Lotan et al [4] reported that lymphovascular invasion was associated with poor prognosis in BC, several studies have confirmed this observation, showing that the presence of tumor cells within vascular spaces is a predictor of nodal metastasis, recurrence and cancer specific death [5,6,7,8,9,10,11,12,13]. Most of these studies did not discriminate between tumor cells in blood vessels and lymphatic vasculature, and the feature of invasion is often reported aslymphovascular. If vascular and lymphatic invasion share the same prognostic traits remains unclear

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call